Arik Zucker

CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany.

Part of Schibsted ASA, 20 Minuten-Holding AG is a holding group with interests in publishing. The company is based in Zurich, Switzerland. The Swiss company was founded by Hans Christoph Tanner. Sverre Christian Munck has been the CEO of the company since 2002.

IVF HARTMANN AG engages in the development and production of medical, pharmaceutical, and hygiene products. It offers dental products, elastic bandages, wound treatment solutions, and personal healthcare products. The company was founded in 1870 and is headquartered in Neuhausen, Switzerland.

Ernst Mueller Moehl provides investment services. The private company is based in Zurich, Switzerland. and has subsidiaries in Switzerland.

Part of Boston Scientific Corp., Schneider (Europe) GmbH is a Swiss company that makes stents used to prop open arteries and other devices for angioplasty. The company is based in Bulach, Switzerland. Schneider (Europe was acquired by Boston Scientific Corp. from Pfizer Inc. on September 10, 1998 for $2,100 million.

Part of SCHWENK Zement GmbH & Co. KG, Vlesia AG is a Swiss company that provides incontinence treatment products. The company is based in Goldach, Switzerland. The CEO of the company is Suk-Woo Ha. Vlesia was acquired by IVF HARTMANN AG from DSG -TEK Ltd on October 01, 2000 for $6.36 million.

20 Minuten AG publishes newspapers and provides online information services. It also provides French-language edition 20 minutes for the French-speaking agglomerations of Geneva and Lausanne. In France, the identically named 20 minutes editions are published by Schibsted and Ouest-France. The company is headquartered in Zurich, Switzerland.

Institut Straumann AG operates a dentistry group. It engages in the research, development and manufacturing dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions. The company is headquartered in Basel, Switzerland.

UBS South Africa (Pty) Ltd. (UBSSA) is the broker subsidiary of UBS AG, which is ultimately held by UBS Group AG (NYSE: UBS). The firm is headquartered in Johannesburg. UBSSA provides brokerage services to private, institutional and corporate clients.

Cosmo Holding SpA manufactures and markets pharmaceutical products. It develops technologies in the sector of modified drug release with oral, topical, and transmucosal applications. The company was founded in 1996 and is headquartered in Milan, Italy.

Part of SCHWENK Zement GmbH & Co. KG, Bode AG is a Swiss company that manufactures hygiene and disinfection products. The company is based in Münchenstein, Switzerland. The CEO of the company is Suk-Woo Ha. Bode was acquired by IVF HARTMANN AG from SCHWENK Zement GmbH & Co. KG on September 03, 2009.

Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland.

Joimax GmbH focuses on innovative technologies, systems and methods for endoscopic minimally invasive spinal surgery. Its products include endoscopic systems, spinal implants, pain therapy systems, VBA management programs, endoscopic devices and user protection. The company was founded by Wolfgang Ries in November 2001 and is headquartered in Karlsruhe, Germany.

Part of UBS Group AG, UBS Australia Pty Ltd. is an Australian company that provides wealth management, asset management and investment banking services. The company is based in Sydney, Australia. The CEO of the company is Matthew Grounds.

FASMED operates as a membership organization for medical device technologies. The private company is based in Muri, Switzerland.

Memo Therapeutics AG develops recombinant immunoglobulins and human-derived monoclonal antibodies. Its products include human antibodies, human immune repertoire analysis, classic antibody discovery and pipeline. The company was founded by Christoph Esslinger on November 29, 2012 and is headquartered in Basel, Switzerland.

FARa Holz AG is a timber trading company based in Zug, Switzerland. FARa Holz is located at Sagistrasse 10, 6300 Zug, Switzerland. The Swiss company specializes in providing wood materials for construction, including wooden structures, cover parking chains, and laminated wood. The private company also offers wood declaration services, advice, and technology. FARa Holz has a team of specialists with many years of experience in the timber trade, and they cater to wooden builders, carpenters, floor layers, roofers, and other woodworking companies. The company also provides advice to architects and construction planners. The company's mission is to have the most satisfied customers in their performance area and the most motivated employees.

Wyss Zurich is an accelerator/incubator with headquarters in Zurich, Switzerland. The firm was founded in 2015.

Lifematrix Technologies AG develops human cell-derived and off-the-shelf available tissue-engineered implants. The company is based in Zurich, Switzerland. The Swiss company was founded by René Stenger and Robin Müller. The CEO is Maximilian Emmert.